Martin Murgier

[Eddy J. Gutierrez, MD @eddyjoemd]

Nasal high flow oxygen is a tool I use daily in the ICU. The ROX index can also be helpful in certain situations. Here's how those two work. 🎩 tip to the authors.
https://t.co/Sfr6vCn6le

[Laurent Bertoletti @LaurentBertole1]

😱 quel succès pour la future Journée Stéphanoise de Vasculaire !
En moins de 3 semaines, les capacités d'accueil sont déjà remplies aux 2 tiers 👏
⌚ dépêchez vous pour les dernières places, à la différence des années précédentes, il ne sera pas possible de "pousser les murs"

[M Velia Antonini @FOAMecmo]

Volume of resuscitation fluids in adult critically ill patients, @ESICM clinical practice guideline on fluid therapy - part 2️⃣ providing 4 conditional + 4 ungraded best practice statements, no recommendations for 2 questions.
🧫 💦 #sepsis or septic shock: administer up to 30 ml/kg of IV crystalloids in initial phase (suggested), with adjustments based on clinical context + frequent reassessments; use an individualized approach in optimization phase. No recommendation for/against systematic restrictive or liberal fluid strategy in optimization phase
🩸💦 hemorrhagic shock: restrictive fluid #resuscitation strategy (suggested as part of a permissive hypotension approach) after blunt or penetrating trauma + guide fluid administration by hemodynamic & biochemical parameters for hemorrhagic shock of non-traumatic origin (recommended/best practice statement)
🫀💦 do not use of fluid resuscitation as primary treatment for circulatory failure due to left-sided cardiogenic shock (recommended/best practice statement); cautiously administer fluids as temporary measure until definitive treatment can be given if cardiac tamponade; cautiously administer fluids with clinical decisions based on measured surrogate markers of right heart congestion for circulatory failure due to pulmonary embolism
🫁 💦 no recommendation for circulatory failure associated with #ARDS
🔓 https://t.co/dEJ6IilFkB

PS Part 1️⃣ the choice of resuscitation fluids
🔓 https://t.co/wAcx6TWemR

[Laurent Bertoletti @LaurentBertole1]

🚨 SAVE THE DATE ! 🚨
La 3ᵉ Journée Stéphanoise de Vasculaire arrive ! 🔬🩸
Au programme :
✅ Pathologies artérielles, veineuses & lymphatiques
✅ Thérapeutiques innovantes
✅ @VerhammePeter en invité d'honneur !
⤵️

#JSV2025

[Lai Christopher @LaiChristopher2]

Should we abandon Prone Postion for patient under VV-#ECMO?
Insight of PRONECMO w/ @PrMatthieuSchmidt
Not for every patients but… 📋
✅no ultra-low Vt
✅bilateral posterior consolidation
✅non-COVID19 ards
✅trained teams
@ISICEM @JAMANetwork #ICU

🔗 10.1001/jama.2023.24491

[GIHP @GIHP_official]

Tryptique. Panneau 1.

Vous n’avez rien de prévu samedi 15 mars? Par chance le GIHP fait sa masterclass annuelle à cette date! Et à Saint-Etienne.🏨💉🩸🌡️💊🩹📝
Venez donc discuter d’hémostase, de thrombose et d’hémorragie!
Inscription: [email protected]
@SFAR_ORG

[M Velia Antonini @FOAMecmo]

Using toxidromes in #ICU to quickly identify likely toxicant class, initiate immediate specific treatment (if available) + guide monitoring in poisoned pts & early detect poisoning in exposed but asymptomatic pts
🪜stepwise approach: vital sign, physical examination, bedside tests, synthesizing findings to identify toxidrome
☠️classic toxidromes: sedative/hypnotic & opioid, anticholinergic & sympathomimetic, serotonin & NMS, cholinergic, extended toxidromes
On @yourICM
🔗https://t.co/MeZJbRBthT

[Intensive Care Medicine @yourICM]

CMV in #ICU: be aware!
🩺 pathophysiology
🧫 infection & disease definitions
🔥 reactivation in non-immunocompromised pts
🕯️ CMV in immunocompromised critically ill
⚠️ incidence & risk factors
🔬 presentations & diagnosis
🩺 treatment & prevention
🔓 https://t.co/vFJtJInxpe

[M Velia Antonini @FOAMecmo]

Permissive hypercapnia in acute severe respiratory failure: should we target PaCO2, pH or both?? Safe thresholds in critically ill?
🩺mechanisms & management of hypercapnia requiring IMV
🫁 impact of hypercapnia on outcomes
🫁 🫀🧠significant physiological effects: RV & pulmonary circulation, brain & other organs
Hypercapnic acidemia during lung-protective MV may have significant consequences, and perhaps should not be a goal per se, but prompt early consideration of adjunctive therapies. Open access #FOAMcc
🔓 https://t.co/9XnMnu5TzW

[Intensive Care Medicine @yourICM]

Gattinoni’s legacy?
🫁personalizing #ARDS management through approach integrating physiology, biology, imaging, cutting-edge trial design/analysis
🔗 https://t.co/wAyQknWm21
💡Refers to study suggesting oxygenation impairment fails to predict VILI risk
🔓 https://t.co/tKTLjb0bBQ

[Intensive Care Medicine @yourICM]

Using the ventilator to predict fluid responsiveness
🫀pulse pressure & stroke volume variation (PPV & SVV)
🖥️ vena cava diameter changes
🫁 Vt challenge
🫁 end-expiratory occlusion test
🫁 recruitment maneuvers
🫁 PEEP test
⁉️ how to select right tool?
🔓 https://t.co/raPaHPCv94

[Laurent Bertoletti @LaurentBertole1]

@mark_toshner @Montanidavid @pulmotension @InsermU999 @HTaPFrance @SPLF_SocPneumo Here is our proposed algorithm for PAH

[Intensive Care Medicine @yourICM]

Spontaneous breathing trials? GLOBAL WEAN study
🩺100 #ICU adults
🫁unassisted SBTs PSV0PEEP0 & T-piece trial most appropriate to replicate postextubation effort to breathe
🪡personalized approach according to critical illness may improve SBT performance
🔓https://t.co/UkMNBgdlym

[Intensive Care Medicine @yourICM]

#POCUS checklist in VA #ECMO
🖥️ cannula position/drainage insufficiency
🖥️ aortic VTI & required EBF
🖥️ AV opening
🖥️ venting
🖥️ pericardial effusion/tamponade
🖥️ settings of right-sided #ECLS + LV support
🖥️ ECMO still needed?
🖥️ post-ECMO complications
🔓https://t.co/A1eeVpxRks

[SRLF @La_SRLF]

Étude REHALITE

Le recrutement des centres démarre cet automne, pour une soumission au CPP avant la Toussaint. Si vous souhaitez participer, contactez la CERC par mail (comcerc.srlf+rehalité@gmail.com).

Date limite : 18/10/2024

En savoir plus : https://t.co/9Jni0snpPn

[SRLF @La_SRLF]

La prochaine Masterclass, consacrée au SDRA, se tiendra les du 12 et 13 décembre 2024, à la SLRF à Paris.
Une Masterclass... bientôt complète ! Venez vite vous inscrire !

Programme et inscription : https://t.co/36wvgw66dT
#SRLF #SDRA

[Intensive Care Medicine @yourICM]

CAR-T cell therapy
🔥 CRS cytokine release syndrome
🧠 neurotoxicity + movement & neurocognitive adverse events
📉 pseudoprogression
🩸 hematotoxicity
🧫 hypogammaglobulinemia & infections
🩸 hemophagocytic lymphohistiocytosis
🫀 cardiotoxicity
#FOAMcc
🖇️ https://t.co/t0mwBVoWAT

[Intensive Care Medicine @yourICM]

Treating acute encephalitis
💉antimicrobial therapy
🧠dexamethasone
⚡️antiseizure drugs
🔍diagnostic studies
⚠️when to suspect/treat autoimmune cause?
Comprehensive/individualized approach critical for appropriate indications & to optimize outcomes.
🖇️ https://t.co/lwF9mgfMlB

[Intensive Care Medicine @yourICM]

Intubation in critical adults with physiologically difficult airway, consensus & expert statements @SOCCA_CritCare
➡️location + factors ⬆️complications
➡️team preparation + human factors
➡️pt preparation & optimization
➡️procedure
➡️post‑intubation care
🖇️ https://t.co/n1YZVhx2aH

[SRLF @La_SRLF]

Santé publique France et l’ARS Auvergne Rhône Alpes investiguent un épisode de cas groupés d’infections par le virus de l’encéphalite à tiques (TBE) survenus en juin 2024.

Lire le communiqué : https://t.co/O4rCXpqGZQ